|Specialist Investment Company
of the Year
|Parex Asset Management
|Click on the play button on the left to watch a video of the award presentation.|
“Innovative” is how the judges described Medical Strategy, which is shortlisted for the second year. All that held the firm back, the judges said, was the level of assets under management. The firm specialises in the the healthcare sector, with a focus on mid to small-cap companies. Its employees are drawn from backgrounds such as medicine, as well as finance. Ashmore Investment Management
Ashmore has a strong leadership position in emerging markets. Judges were attracted by the firm’s vision, which includes attracting emerging market investors from the emerging markets themselves. The firm is well known for its dollar debt strategy and is a leader in local currency with ten years of experience and $7bn under management. In its Special Situations strategy, Ashmore controls companies with a combined market cap of over $20bn. Charlemagne Capital
Charlemagne Capital is an independent manager that invests only in emerging market equities. Access to equities is provided in a number of ways. For example, its Magna long-only funds offer exposure on a global, regional and country-specific basis, while its OCCO funds are market neutral long-short funds which aim to deliver absolute returns over the medium term. Culross Global Management
Culrosss Global Management is a ‘forward-looking’, thematic fund of hedge funds manager that was founded in 1992. It has a three-stage approach to portfolio construction, which consists first of selecting investment themes, and then of selecting the right technique. Finally, rather than select the best manager on past performance (a backward-looking approach), the firm seeks the manager best suited to the appropriate technique.